{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:00:49Z","timestamp":1786122049509,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["No. ZR2023MH327"],"award-info":[{"award-number":["No. ZR2023MH327"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014761","name":"Natural Science Foundation of Qingdao Municipality","doi-asserted-by":"crossref","award":["No. 23-2-1-193-zyyd-jch"],"award-info":[{"award-number":["No. 23-2-1-193-zyyd-jch"]}],"id":[{"id":"10.13039\/501100014761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Qingdao Key Medical and Health Discipline Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04717-7","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T01:33:15Z","timestamp":1749173595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Silencing FGL1 promotes prostate cancer cell apoptosis and inhibits EMT progression"],"prefix":"10.1038","volume":"15","author":[{"given":"Shuaizhi","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengshun","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"issue":"6","key":"4717_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 68 (6), 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"Cancer J. Clin."},{"issue":"1","key":"4717_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. Cancer J. Clin. 69 (1), 7\u201334. https:\/\/doi.org\/10.3322\/caac.21551 (2019).","journal-title":"Cancer J. Clin."},{"key":"4717_CR3","doi-asserted-by":"publisher","first-page":"105644","DOI":"10.1016\/j.biocel.2019.105644","volume":"118","author":"FY Khusbu","year":"2020","unstructured":"Khusbu, F. Y. et al. Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration. Int. J. Biochem. Cell Biol. 118, 105644. https:\/\/doi.org\/10.1016\/j.biocel.2019.105644 (2020).","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"17\u201318","key":"4717_CR4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1101\/gad.315739.118","volume":"32","author":"G Wang","year":"2018","unstructured":"Wang, G., Zhao, D., Spring, D. J. & DePinho, R. A. Genetics and biology of:prostate cancer. Genes Dev. 32 (17\u201318), 1105\u20131140. https:\/\/doi.org\/10.1101\/gad.315739.118 (2018).","journal-title":"Genes Dev."},{"issue":"1","key":"4717_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello, R. J. et al. Prostate cancer. Nat. Reviews Disease Primers. 7 (1), 9. https:\/\/doi.org\/10.1038\/s41572-020-00243-0 (2021).","journal-title":"Nat. Reviews Disease Primers"},{"issue":"4","key":"4717_CR6","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.eururo.2016.08.002","volume":"71","author":"P Cornford","year":"2017","unstructured":"Cornford, P. et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and Castration-Resistant prostate Cancer. Eur. Urol. 71 (4), 630\u2013642. https:\/\/doi.org\/10.1016\/j.eururo.2016.08.002 (2017).","journal-title":"Eur. Urol."},{"issue":"8","key":"4717_CR7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1056\/NEJMoa1503747","volume":"373","author":"CJ Sweeney","year":"2015","unstructured":"Sweeney, C. J. et al. Chemohormonal therapy in metastatic Hormone-Sensitive prostate Cancer. N. Engl. J. Med. 373 (8), 737\u2013746. https:\/\/doi.org\/10.1056\/NEJMoa1503747 (2015).","journal-title":"N. Engl. J. Med."},{"key":"4717_CR8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-med-051517-011947","volume":"70","author":"MY Teo","year":"2019","unstructured":"Teo, M. Y., Rathkopf, D. E. & Kantoff, P. Treatment of advanced prostate Cancer. Annu. Rev. Med. 70, 479\u2013499. https:\/\/doi.org\/10.1146\/annurev-med-051517-011947 (2019).","journal-title":"Annu. Rev. Med."},{"key":"4717_CR9","doi-asserted-by":"publisher","unstructured":"Parker, C. et al. &. Electronic address: clinicalguidelines@esmo.org Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 31 (9), 1119\u20131134. https:\/\/doi.org\/10.1016\/j.annonc.2020.06.011 (2020).","DOI":"10.1016\/j.annonc.2020.06.011"},{"issue":"12","key":"4717_CR10","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/modpathol.3800674","volume":"19","author":"KY Chan","year":"2006","unstructured":"Chan, K. Y. et al. Positional expression profiling indicates candidate genes in deletion hotspots of hepatocellular carcinoma. Mod. Pathology: Official J. United States Can. Acad. Pathol. Inc. 19 (12), 1546\u20131554. https:\/\/doi.org\/10.1038\/modpathol.3800674 (2006).","journal-title":"Mod. Pathology: Official J. United States Can. Acad. Pathol. Inc"},{"issue":"2","key":"4717_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.bbrc.2015.07.078","volume":"465","author":"H Nayeb-Hashemi","year":"2015","unstructured":"Nayeb-Hashemi, H. et al. Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development. Biochem. Biophys. Res. Commun. 465 (2), 167\u2013173. https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.078 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"4717_CR12","doi-asserted-by":"crossref","unstructured":"Wang, J., Sanmamed, M. F., Datar, I., Su, T. T., Ji, L., Sun, J., Chen, L., Chen,Y., Zhu, G., Yin, W., Zheng, L., Zhou, T., Badri, T., Yao, S., Zhu, S., Boto, A.,Sznol, M., Melero, I., Vignali, D. A. A., Schalper, K., \u2026 Chen, L. Fibrinogen-like protein 1 Is a major immune inhibitory ligand of LAG-3. Cell 176 (1\u20132), 334\u2013347.e12. (2019).","DOI":"10.1016\/j.cell.2018.11.010"},{"issue":"1","key":"4717_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13045-021-01161-8","volume":"14","author":"W Qian","year":"2021","unstructured":"Qian, W., Zhao, M., Wang, R. & Li, H. Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target. J. Hematol. Oncol. 14 (1), 147. https:\/\/doi.org\/10.1186\/s13045-021-01161-8 (2021).","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"4717_CR14","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.3390\/ijms22084109","volume":"22","author":"MM Kgatle","year":"2021","unstructured":"Kgatle, M. M. et al. Immune checkpoints, inhibitors and radionuclides in prostate cancer: promising combinatorial therapy approach. Int. J. Mol. Sci. 22 (8), 4109. https:\/\/doi.org\/10.3390\/ijms22084109 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"4717_CR41","doi-asserted-by":"publisher","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","DOI":"10.1002\/pro.3715"},{"key":"4717_CR15","doi-asserted-by":"crossref","unstructured":"Lehti\u00f6, J., Arslan, T., Siavelis, I., Pan, Y., Socciarelli, F., Berkovska, O., Umer,H. M., Mermelekas, G., Pirmoradian, M., J\u00f6nsson, M., Brunnstr\u00f6m, H., Brustugun, O.T., Purohit, K. P., Cunningham, R., Foroughi Asl, H., Isaksson, S., Arbajian, E.,Aine, M., Karlsson, A., Kotevska, M., \u2026 Orre, L. M. Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms. Nat. Cancer 2 (11), 1224\u20131242. (2021).","DOI":"10.1038\/s43018-021-00259-9"},{"issue":"1","key":"4717_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12931-020-01477-y","volume":"21","author":"C Sun","year":"2020","unstructured":"Sun, C., Gao, W., Liu, J., Cheng, H. & Hao, J. FGL1 regulates acquired resistance to gefitinib by inhibiting apoptosis in non-small cell lung cancer. Respir. Res. 21 (1), 210. https:\/\/doi.org\/10.1186\/s12931-020-01477-y (2020).","journal-title":"Respir. Res."},{"issue":"16","key":"4717_CR17","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1111\/febs.14936","volume":"286","author":"DA Roosen","year":"2019","unstructured":"Roosen, D. A., Blauwendraat, C., Cookson, M. R. & Lewis, P. A. DNAJC proteins and pathways to parkinsonism. FEBS J. 286 (16), 3080\u20133094. https:\/\/doi.org\/10.1111\/febs.14936 (2019).","journal-title":"FEBS J."},{"issue":"6","key":"4717_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3892\/ijmm.2021.4938","volume":"47","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. DNAJC12 promotes lung cancer growth by regulating the activation of \u03b2catenin. Int. J. Mol. Med. 47 (6), 105. https:\/\/doi.org\/10.3892\/ijmm.2021.4938 (2021).","journal-title":"Int. J. Mol. Med."},{"issue":"7","key":"4717_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro, B. A. & El-Deiry, W. S. Targeting apoptosis in cancer therapy. Nat. Rev. Clin. Oncol. 17 (7), 395\u2013417. https:\/\/doi.org\/10.1038\/s41571-020-0341-y (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"4717_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4161\/cbt.4.2.1508","volume":"4","author":"Z Jin","year":"2005","unstructured":"Jin, Z. & El-Deiry, W. S. Overview of cell death signaling pathways. Cancer Biol. Ther. 4 (2), 139\u2013163. https:\/\/doi.org\/10.4161\/cbt.4.2.1508 (2005).","journal-title":"Cancer Biol. Ther."},{"key":"4717_CR21","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.12659\/msm.901381","volume":"23","author":"C Yao","year":"2017","unstructured":"Yao, C. et al. Boschniakia Rossica polysaccharide triggers laryngeal carcinoma cell apoptosis by regulating expression of Bcl-2, Caspase-3, and P53. Med. Sci. Monitor: Int. Med. J. Experimental Clin. Res. 23, 2059\u20132064. https:\/\/doi.org\/10.12659\/msm.901381 (2017).","journal-title":"Med. Sci. Monitor: Int. Med. J. Experimental Clin. Res."},{"issue":"8","key":"4717_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.21037\/atm-22-1475","volume":"10","author":"J Wang","year":"2022","unstructured":"Wang, J., Huang, H. & Liu, F. DNAJC12 activated by HNF1A enhances aerobic Glycolysis and drug resistance in non-small cell lung cancer. Annals Translational Med. 10 (8), 492. https:\/\/doi.org\/10.21037\/atm-22-1475 (2022).","journal-title":"Annals Translational Med."},{"issue":"3","key":"4717_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/ijms20030473","volume":"20","author":"CW Chu","year":"2019","unstructured":"Chu, C. W. et al. Thioridazine enhances P62-Mediated autophagy and apoptosis through Wnt\/\u03b2-Catenin signaling pathway in glioma cells. Int. J. Mol. Sci. 20 (3), 473. https:\/\/doi.org\/10.3390\/ijms20030473 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"4717_CR24","doi-asserted-by":"publisher","first-page":"23598","DOI":"10.18632\/aging.103546","volume":"12","author":"L Sha","year":"2020","unstructured":"Sha, L., Ma, D. & Chen, C. Exosome-mediated Hic-5 regulates proliferation and apoptosis of osteosarcoma via Wnt\/\u03b2-catenin signal pathway. Aging 12 (23), 23598\u201323608. https:\/\/doi.org\/10.18632\/aging.103546 (2020).","journal-title":"Aging"},{"issue":"3","key":"4717_CR25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1158\/1541-7786.MCR-18-0500","volume":"17","author":"B Uygur","year":"2019","unstructured":"Uygur, B. et al. Interactions with muscle cells boost fusion, stemness, and drug resistance of prostate Cancer cells. Mol. cancer Research: MCR. 17 (3), 806\u2013820. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0500 (2019).","journal-title":"Mol. cancer Research: MCR"},{"issue":"2","key":"4717_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1249\/MSS.0000000000002783","volume":"54","author":"JS Kim","year":"2022","unstructured":"Kim, J. S. et al. Myokine expression and Tumor-Suppressive effect of serum after 12 Wk of exercise in prostate Cancer patients on ADT. Med. Sci. Sports. Exerc. 54 (2), 197\u2013205. https:\/\/doi.org\/10.1249\/MSS.0000000000002783 (2022).","journal-title":"Med. Sci. Sports. Exerc."},{"issue":"11","key":"4717_CR27","doi-asserted-by":"publisher","first-page":"a029793","DOI":"10.1101\/cshperspect.a029793","volume":"7","author":"C Hoffmann","year":"2017","unstructured":"Hoffmann, C. & Weigert, C. Skeletal muscle as an endocrine organ: the role of myokines in exercise adaptations. Cold Spring Harbor Perspect. Med. 7 (11), a029793. https:\/\/doi.org\/10.1101\/cshperspect.a029793 (2017).","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"4717_CR28","doi-asserted-by":"crossref","unstructured":"Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., Campbell,K., Cano, A., Casanova, J., Christofori, G., Dedhar, S., Derynck, R., Ford, H. L.,Fuxe, J., Garc\u00eda de Herreros, A., Goodall, G. J., Hadjantonakis, A. K., Huang, R.Y. J., Kalcheim, C., Kalluri, R., \u2026 EMT International Association (TEMTIA). Guidelines and definitions for research on epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 21 (6), 341\u2013352. (2020).","DOI":"10.1038\/s41580-020-0237-9"},{"issue":"11","key":"4717_CR29","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41419-022-05285-8","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. MACC1 promotes pancreatic cancer metastasis by interacting with the EMT regulator SNAI1. Cell Death Dis. 13 (11), 923. https:\/\/doi.org\/10.1038\/s41419-022-05285-8 (2022).","journal-title":"Cell Death Dis."},{"issue":"13","key":"4717_CR30","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.3390\/nu15132884","volume":"15","author":"H Hajimehdipoor","year":"2023","unstructured":"Hajimehdipoor, H., Tahmasvand, Z., Nejad, F. G., Maresca, M. & Rajabi, S. Rutin promotes proliferation and orchestrates Epithelial-Mesenchymal transition and angiogenesis in MCF-7 and MDA-MB-231 breast Cancer cells. Nutrients 15 (13), 2884. https:\/\/doi.org\/10.3390\/nu15132884 (2023).","journal-title":"Nutrients"},{"key":"4717_CR31","doi-asserted-by":"crossref","unstructured":"Li, X. F., Selli, C., Zhou, H. L., Cao, J., Wu, S., Ma, R. Y., Lu, Y., Zhang, C. B.,Xun, B., Lam, A. D., Pang, X. C., Fernando, A., Zhang, Z., Unciti-Broceta, A., Carragher,N. O., Ramachandran, P., Henderson, N. C., Sun, L. L., Hu, H. Y., Li, G. B., \u2026 Qian,B. Z. Macrophages promote anti-androgen resistance in prostate cancer bone disease.J. Exp. Med. 220 (4), e20221007. (2023).","DOI":"10.1084\/jem.20221007"},{"issue":"3","key":"4717_CR32","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1007\/s10528-023-10545-z","volume":"62","author":"Z Pan","year":"2024","unstructured":"Pan, Z. et al. Increased FGL1 expression predicts poor prognosis and promotes EMT in head and neck squamous cell carcinoma. Biochem. Genet. 62 (3), 2066\u20132081. https:\/\/doi.org\/10.1007\/s10528-023-10545-z (2024).","journal-title":"Biochem. Genet."},{"key":"4717_CR33","doi-asserted-by":"publisher","first-page":"756843","DOI":"10.3389\/fonc.2021.756843","volume":"11","author":"Z Lv","year":"2021","unstructured":"Lv, Z. et al. FGL1 as a novel mediator and biomarker of malignant progression in clear cell renal cell carcinoma. Front. Oncol. 11, 756843. https:\/\/doi.org\/10.3389\/fonc.2021.756843 (2021).","journal-title":"Front. Oncol."},{"issue":"2","key":"4717_CR34","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3892\/mmr.2018.9097","volume":"18","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Qiao, H. X., Zhou, Y. T., Hong, L. & Chen, J. H. Fibrinogen\u2013like\u2013protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis. Mol. Med. Rep. 18 (2), 1465\u20131472. https:\/\/doi.org\/10.3892\/mmr.2018.9097 (2018).","journal-title":"Mol. Med. Rep."},{"key":"4717_CR35","doi-asserted-by":"publisher","first-page":"810269","DOI":"10.3389\/fonc.2022.810269","volume":"12","author":"Q Yan","year":"2022","unstructured":"Yan, Q. et al. Immune checkpoint FGL1 expression of Circulating tumor cells is associated with poor survival in curatively resected hepatocellular carcinoma. Front. Oncol. 12, 810269. https:\/\/doi.org\/10.3389\/fonc.2022.810269 (2022).","journal-title":"Front. Oncol."},{"issue":"11","key":"4717_CR36","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan, T., Rindtorff, N. & Boutros, M. Wnt signaling in cancer. Oncogene 36 (11), 1461\u20131473. https:\/\/doi.org\/10.1038\/onc.2016.304 (2017).","journal-title":"Oncogene"},{"issue":"4","key":"4717_CR37","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/sj.onc.1202653","volume":"18","author":"E Latres","year":"1999","unstructured":"Latres, E., Chiaur, D. S. & Pagano, M. The human F box protein beta-Trcp associates with the Cul1\/Skp1 complex and regulates the stability of beta-catenin. Oncogene 18 (4), 849\u2013854. https:\/\/doi.org\/10.1038\/sj.onc.1202653 (1999).","journal-title":"Oncogene"},{"issue":"1","key":"4717_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12967-020-02469-8","volume":"18","author":"M Guo","year":"2020","unstructured":"Guo, M. et al. Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8+T cells in hepatocellular carcinoma using multiplex quantitative analysis. J. Translational Med. 18 (1), 306. https:\/\/doi.org\/10.1186\/s12967-020-02469-8 (2020).","journal-title":"J. Translational Med."},{"issue":"4","key":"4717_CR39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3892\/ol.2022.13455","volume":"24","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. tRNA-derived fragment tRF-Glu49 inhibits cell proliferation, migration and invasion in cervical cancer by targeting FGL1. Oncol. Lett. 24 (4), 334. https:\/\/doi.org\/10.3892\/ol.2022.13455 (2022).","journal-title":"Oncol. Lett."},{"issue":"7","key":"4717_CR40","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.3390\/ijms22073753","volume":"22","author":"MT Vietri","year":"2021","unstructured":"Vietri, M. T. et al. Hereditary prostate cancer: genes related, target therapy and prevention. Int. J. Mol. Sci. 22 (7), 3753. https:\/\/doi.org\/10.3390\/ijms22073753 (2021).","journal-title":"Int. J. Mol. Sci."}],"updated-by":[{"DOI":"10.1038\/s41598-026-65278-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04717-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04717-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04717-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T07:54:12Z","timestamp":1786089252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04717-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4717"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04717-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"19 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-65278-x","URL":"https:\/\/doi.org\/10.1038\/s41598-026-65278-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Qingdao Municipal Hospital affiliated with Qingdao University and Qingdao University approved this research.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"19886"}}